About

Publications While At HealthPartners

selected publications

Journal Article

A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872. 

Cancer. 2019

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG). 

Journal of Neuro-Oncology. 2019

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572. 

Cancer. 2018

Contact

full name

C. Giannini

Quick Info

 

Collaboration

Co-author network

Map of science